Study for adults with heart rhythm problems
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial is a “clinical cohort” study, meaning it follows adults with certain heart rhythm issues to understand them better. Your participation may help researchers learn what to expect and how best to support people over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have a heart rhythm problem (an arrhythmia) or are at high risk for one
- You can read and understand the study paperwork and give written consent
- You must be able to communicate in German well enough to do interviews and understand documents without an interpreter
- You are physically and mentally able to take part in study activities and answer questions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to better judge a person’s risk of developing atrial fibrillation, a type of irregular heartbeat. You may help researchers by completing interviews and assessments that guide future risk estimates.
This study looks at how heart rhythm problems affect heart function. It may help doctors better understand and treat these conditions.
This registry collects information from people who have had or are scheduled to have a heart rhythm test or a procedure to restore a normal heartbeat at University Hospital Düsseldorf. It helps doctors understand more about heart rhythm problems and treatments over time.
This is a hospital-based study that collects standardized information about adults with specific heart conditions—heart failure, coronary artery disease, or atrial fibrillation. It may help doctors and researchers better understand these diseases and improve future care.
This study uses a special ECG to better tell apart different types of fast heart rhythms in people scheduled for a procedure called ablation. The goal is to improve diagnosis and treatment for conditions like atrial fibrillation and other supraventricular tachycardias.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
Hear when a new Arrhythmias, Cardiac trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.